ACC: AstraZeneca's clot-busting Brilinta matches Plavix safety in high-risk heart attack patients
admin 11th March 2018 Uncategorised 0AstraZeneca just may have found a new niche for blood thinner Brilinta. Sunday, the British pharma giant presented data showing the med was as safe as the standard therapy clopidogrel—known in the branded world as Sanofi’s Plavix—when used to treat some high-risk heart attack patients.
More: ACC: AstraZeneca's clot-busting Brilinta matches Plavix safety in high-risk heart attack patients
Source: fierce